About Priovant Therapeutics
Developing targeted therapies for patients with severe autoimmune disease
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Durham, NC
- Company type
- Privately Held
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens. We are rapidly developing a pipeline of medicines targeted to the specific molecular dysregulations underlying severe autoimmune conditions, unlocking new treatment options for patients who are underserved by existing therapies.
Company locations
Durham, NC 27703, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 5,759
- People linked to this company
- 94
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.